NCT01183819

Brief Summary

The purpose of this study is to test the hypothesis that aerobic exercise and a computer-based cognitive intervention leads to improved cognitive function accompanied by increases in gray matter density and changes in functional magnetic resonance imaging (fMRI) patterns of task-related activation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 16, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 18, 2010

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

August 5, 2015

Status Verified

August 1, 2015

Enrollment Period

5.3 years

First QC Date

August 16, 2010

Last Update Submit

August 3, 2015

Conditions

Keywords

cognitive functionfMRIapoEinflammatory markersexercisecognitive interventionSpace Fortress

Outcome Measures

Primary Outcomes (1)

  • Changes in measures of executive control function and episodic memory at 6 months

    tests of global intelligence, executive function, working memory and processing speed

    Baseline and 12 weeks

Secondary Outcomes (3)

  • Changes in brain structure, resting cerebral blood flow and network efficiency at 6 months

    Baseline and 12 weeks

  • Change in aerobic capacity at 6 months

    Baseline and 12 weeks

  • Changes in measures of executive control function and episodic memory at 1 year

    Baseline and 52 weeks

Study Arms (3)

Space Fortress and Exercise

EXPERIMENTAL

Participants engage in aerobic exercise 4 times week and Space Fortress sessions 3 times a week for a total of 12 weeks.

Behavioral: Space FortressBehavioral: Aerobic Exercise

Control Games and Exercise

ACTIVE COMPARATOR

Participants engage in aerobic exercise 4 times a week and control game sessions 3 times a week for a total of 12 weeks.

Behavioral: Aerobic ExerciseBehavioral: Control Games

Control Games and Stretching

ACTIVE COMPARATOR

Participants engage in stretching/toning exercises 4 times a week and control game sessions 3 times a week for a total of 12 weeks.

Behavioral: StretchingBehavioral: Control Games

Interventions

Space FortressBEHAVIORAL

Space Fortress sessions 3 times a week for 12 weeks

Space Fortress and Exercise

Aerobic Exercise 4 times a week for 12 weeks

Control Games and ExerciseSpace Fortress and Exercise
StretchingBEHAVIORAL

Stretching/Toning exercise 4 times a week for 12 weeks.

Control Games and Stretching
Control GamesBEHAVIORAL

Control games session 3 times a week for 12 weeks

Control Games and ExerciseControl Games and Stretching

Eligibility Criteria

Age60 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 60-75
  • English-speaking
  • Strongly right-handed
  • BMI \> 18.5 and \< 32
  • Post-menopausal (women only): no estrogen replacement therapy
  • Sedentary: VO2max \< 36 ml/kg/min for men age 60-75; \< 29 ml/kg/min for women age 60-75 (determined using Jones Formula Men = (60-(0.55\*AGE)) Women = (48-(.37\*AGE))

You may not qualify if:

  • MRI contraindications (e.g., metallic implants, pacemaker, weight \> 350 lbs, waist \> 55")
  • Hearing impaired/hearing aids, unable to read newspaper at arm's length with corrective lenses
  • Objective cognitive impairment
  • Ischemic changes, abnormal blood pressure responses, or any significant ectopy during aerobic capacity testing
  • Cardiovascular disease
  • Uncontrolled high blood pressure (systolic blood pressure ≥ 180 mmHg; or diastolic blood pressure ≥ 105 mmHg on two measures)
  • Current or recent (evidence of disease x 5 years) non-skin neoplastic disease or melanoma
  • Active hepatic disease (not a history of hepatitis) or primary renal disease requiring dialysis, primary untreated endocrine diseases, e.g., Cushing's disease or primary hypothalamic failure or insulin dependent diabetes (Type I or II).
  • HIV infection
  • Pregnant or lactating (participation allowed 3 months after ceasing lactation
  • Other medical disorders judge to interfere with study
  • Medications that target CNS (e.g., neuroleptics, anticonvulsants, antidepressants, benzodiazepines) within the last month
  • Women: any selective estrogen receptor modulator or aromatase inhibitor Men: androgen ablation/deprivation hormonal therapies
  • Any history of psychosis or electroconvulsive therapy
  • Psychotic disorder (lifetime)
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia University Medical Center

New York, New York, 10032, United States

Location

MeSH Terms

Conditions

Motor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Yaakov Stern, Ph.D.

    Sergievsky Center Columbia University Medical Center

    PRINCIPAL INVESTIGATOR
  • Richard Sloan, Ph.D.

    Behavioral Medicine Columbia University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Clinical

Study Record Dates

First Submitted

August 16, 2010

First Posted

August 18, 2010

Study Start

February 1, 2010

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

August 5, 2015

Record last verified: 2015-08

Locations